Skip to main content
. 2009 Apr 9;3(3):91–98. doi: 10.1111/j.1750-2659.2009.00079.x

Table 1.

 Demographics of the children aged 1–12 years who were evaluated in the analysis (overall, control and rapid test groups)

Overall (n = 16 907) Control (n = 1036) Rapid test (n = 15 871)
Age (years)
 Mean 5·9 5·9 5·9
 SD 3·21 3·20 3·21
Sex
n 16 690 1018 15 672
 Male (n) (%) 8729 (52·3) 553 (54·3) 8176 (52·2)
 Female (n) (%) 7961 (47·7) 465 (45·7) 7496 (47·8)
Vaccinated
n 7277 509 6768
 Yes (n) (%) 903 (12·4) 74 (14·5) 829 (12·2)
 No (n) (%) 6374 (87·6) 435 (85·5) 5939 (87·8)
Chronic pre‐existing illness
 Yes (n) (%) 1904 (11·3) 142 (13·7) 1762 (11·1)
 No (n) (%) 13 991 (82·8) 840 (81·1) 13 151 (82·9)
Pre‐visit medication
 Antipyretics, analgesics and anti‐inflammatories (n) (%) 10 727 (63·4) 714 (68·9) 10 013 (63·1)
 Cough syrups (n) (%) 3831 (22·7) 278 (26·8) 3553 (22·4)
 Others (n) (%) 1419 (8·4) 113 (10·9) 1306 (8·2)
 None (n) (%) 4932 (29·2) 258 (24·9) 4674 (29·4)